Pharmacologic blockade of 5LO modulates tau metabolism, ameliorates synaptic integrity and decreases neuroinflammation in the 3×Tg mice. by Jin Chu (358006)

Fibγ^Δ5 mice display decreased survival following <i>S. aureus</i> peritonitis. by Oscar Negrón (11965511)

Fig 5 - by Héctor Raúl Olivares-Sánchez (13014866)

a-c: Bone marrow (BM) EPO receptor (EPO-R) decreases in uremic anemia rats. by Daniel Landau (440830)

“…<p>BM EPO-R protein (depicted as percentage of actin-corrected concentration) is unchanged in 7 day-bled rats Vs controls (Fig. 4a). Contrary to that BM EPO-R protein decreases in uremic (4 weeks after 5/6 nephrectomy) rats (Fig. 4b). …”

Spleen PAX5 significantly decreased in APRIL/BLyS blockade treated mice. by Natalie M. Bath (6316517)

CcnA mutation of Loop A decreases the interaction with the 5′ UTR of P2-<i>ctrA</i> mRNA and 5′ UTR of <i>gcrA</i> mRNA. by Wanassa Beroual (5314028)

Figure S1 - Cigarette Smoke Decreases Airway Epithelial FABP5 Expression and Promotes <em>Pseudomonas aeruginosa</em> Infection by Fabienne Gally (260470)

Decrease in CLPs, NKPS and Block in NKP progression. by John Richards (53768)

ROS and superoxide decrease in the dormant form of mycobacteria. by Amar Yeware (7115063)

Diverse stress conditions trigger a rapid and dramatic decrease in miR-520b-3p and a corresponding increase in ATF5 mRNA over time in HeLa cells. by Kari A. Gaither (9046190)

Multiple miRNAs decrease telomerase activity. by Radmila Hrdličková (523455)

Suppression of endogenous human TRAM expression decreases R848 mediated <i>CCL5</i> and <i>IFN-β</i>, but not <i>TNF-α</i> expression. by Enda Shevlin (628477)

Preoperative and postoperative questionnaire scores of groups A, B, C, D, E, F, and G. by Régis Cohen (11419436)

Subjects:

Laquinimod prevents EAE and decreases encephalitogenicity of T cells. by Ulf Schulze-Topphoff (174453)

“…<p>DBA/1 (A) mice and C57BL/6 mice (B) were treated daily with laquinimod (25 mg/kg, n = 6/group) or vehicle (water, n = 6/group) starting from the day of immunization with rMOG 1-125 (DBA/1) or MOG p35-55 (C57BL/6). …”

GSH content was decreased in low glucose conditions. by Martine Emery (215947)

BRCA1 silencing decreases cell viability. by Pei Chen (252989)

B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

“…<b>(B)</b> Early glycolytic intermediates and the ratio of F-6-P to F-1,6-BP (<i>lower right</i>) are shown. <b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). …”

MES transiently decreases mitochondrial membrane potential. by Shingo Matsuyama (672132)

Fucoidan decreased lung metastases of breast cancer. by Meilan Xue (310911)

Decreased function of Nrf2 in the aging heart. by Sellamuthu S. Gounder (306106)

“…(<b>B</b>) <b>Transcription factor binding (TransAM-Nrf2 activity) assay:</b> Nuclear proteins from young and aged mice (n = 4) were incubated with the oligonucleotide (pre-coated on 96 well plate/strips) for ARE (antioxidant response element). (<b>C</b>) <b>Localization of Nrf2 by immunofluorescence:</b> Immunofluorescence analysis using anti-Nrf2-ab (1∶200; v/v) showing decreased cytosolic and nuclear Nrf2 in old versus young myocardium. …”